WO2002000662B1 - Improvements in and relating to chromophores - Google Patents
Improvements in and relating to chromophoresInfo
- Publication number
- WO2002000662B1 WO2002000662B1 PCT/GB2001/002846 GB0102846W WO0200662B1 WO 2002000662 B1 WO2002000662 B1 WO 2002000662B1 GB 0102846 W GB0102846 W GB 0102846W WO 0200662 B1 WO0200662 B1 WO 0200662B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- πng
- phenyl
- chromophore
- aryl
- Prior art date
Links
- 150000004032 porphyrins Chemical class 0.000 claims abstract 6
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical compound C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims 34
- 125000003118 aryl group Chemical group 0.000 claims 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 19
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 125000001424 substituent group Chemical group 0.000 claims 10
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 239000002202 Polyethylene glycol Substances 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- -1 cyclopropanyl structure Chemical group 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 229920001223 polyethylene glycol Polymers 0.000 claims 5
- 229910019142 PO4 Inorganic materials 0.000 claims 4
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims 4
- 230000001268 conjugating effect Effects 0.000 claims 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 4
- 125000004043 oxo group Chemical group O=* 0.000 claims 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 4
- 239000010452 phosphate Substances 0.000 claims 4
- 125000005496 phosphonium group Chemical group 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 125000006732 (C1-C15) alkyl group Chemical group 0.000 claims 1
- 239000004721 Polyphenylene oxide Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001299 aldehydes Chemical class 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 150000002016 disaccharides Chemical class 0.000 claims 1
- 150000002118 epoxides Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000001805 pentosyl group Chemical group 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 238000000034 method Methods 0.000 abstract 2
- 238000004458 analytical method Methods 0.000 abstract 1
- BHPNXACHQYJJJS-UHFFFAOYSA-N bacteriochlorin Chemical compound N1C(C=C2N=C(C=C3NC(=C4)C=C3)CC2)=CC=C1C=C1CCC4=N1 BHPNXACHQYJJJS-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000012921 fluorescence analysis Methods 0.000 abstract 1
- 238000000799 fluorescence microscopy Methods 0.000 abstract 1
- NYUABOGYMWADSF-UHFFFAOYSA-N Cc(cc1O)cc(O)c1O Chemical compound Cc(cc1O)cc(O)c1O NYUABOGYMWADSF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K9/00—Tenebrescent materials, i.e. materials for which the range of wavelengths for energy absorption is changed as a result of excitation by some form of energy
- C09K9/02—Organic tenebrescent materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Analytical Chemistry (AREA)
- AIDS & HIV (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/312,347 US20030203888A1 (en) | 2001-06-06 | 2001-06-26 | Chromophores |
NZ523011A NZ523011A (en) | 2000-06-26 | 2001-06-26 | Improvements in and relating to chromophores such as porphyrin, chlorin and bacteriochlorin chromophores |
JP2002505786A JP2004501923A (en) | 2000-06-26 | 2001-06-26 | Chromophore improvement and chromophore improvement |
CA002414089A CA2414089A1 (en) | 2000-06-26 | 2001-06-26 | Improvements in and relating to chromophores |
AU70748/01A AU783640B2 (en) | 2000-06-26 | 2001-06-26 | Improvements in and relating to chromophores |
EP01949625A EP1294726A2 (en) | 2000-06-26 | 2001-06-26 | Improvements in and relating to chromophores |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21407500P | 2000-06-26 | 2000-06-26 | |
US60/214,075 | 2000-06-26 | ||
GB0113784.3 | 2001-06-06 | ||
GB0113784A GB0113784D0 (en) | 2000-06-26 | 2001-06-06 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002000662A1 WO2002000662A1 (en) | 2002-01-03 |
WO2002000662B1 true WO2002000662B1 (en) | 2002-04-04 |
Family
ID=26246162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/002846 WO2002000662A1 (en) | 2000-06-26 | 2001-06-26 | Improvements in and relating to chromophores |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1294726A2 (en) |
JP (1) | JP2004501923A (en) |
AU (1) | AU783640B2 (en) |
CA (1) | CA2414089A1 (en) |
NZ (1) | NZ523011A (en) |
WO (1) | WO2002000662A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0130778D0 (en) * | 2001-12-21 | 2002-02-06 | Catalyst Biomedica Ltd | Novel compounds |
DE102006045307A1 (en) * | 2006-09-26 | 2008-04-03 | Siemens Ag | Electrochromic formulation, method of preparation and electrochromic organic device |
RU2574062C9 (en) * | 2008-09-18 | 2016-10-27 | Биолитек Унтернеменсбетайлигунгс Ii Аг | Novel method and application of unsymmetrically meso-substituted porphyrins and chlorines for pdt |
GB0904825D0 (en) * | 2009-03-20 | 2009-05-06 | Photobiotics Ltd | Biological materials and uses thereof |
EP2526103B1 (en) * | 2010-01-22 | 2016-05-04 | Council of Scientific & Industrial Research | A process for the preparation of novel porphyrin derivatives and their use as pdt agents and fluorescence probes |
CN103575898B (en) * | 2012-07-23 | 2015-09-09 | 苏州长光华医生物试剂有限公司 | A kind ofly detect kit of TPD52L1 albumen and preparation method thereof |
CN103575901B (en) * | 2012-07-23 | 2015-10-21 | 苏州长光华医生物试剂有限公司 | A kind ofly detect kit of EGFR albumen and preparation method thereof |
CN109563532A (en) * | 2016-06-10 | 2019-04-02 | 尼尔瓦纳科学股份有限公司 | Hydrogenation porphyrin bead with narrow fluorescent emission |
US11904026B2 (en) | 2017-02-03 | 2024-02-20 | Nirvana Sciences Inc. | Metallohydroporphyrins for photoacoustic imaging |
KR101879725B1 (en) * | 2017-08-08 | 2018-07-18 | 건국대학교 산학협력단 | A novel diaminomaleonitrile porphyrin derivative, composition for detecting mercury ion comprising the same and method for detecting mercury ion using the same |
CN109734856B (en) * | 2019-01-04 | 2021-07-27 | 华东师范大学 | Porphyrin-end-group-containing amphiphilic polypeptide block copolymer and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8429845D0 (en) * | 1984-11-26 | 1985-01-03 | Efamol Ltd | Porphyrins & cancer treatment |
US6183727B1 (en) * | 1998-05-19 | 2001-02-06 | Arizona Board Of Regents | Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis |
-
2001
- 2001-06-26 JP JP2002505786A patent/JP2004501923A/en active Pending
- 2001-06-26 EP EP01949625A patent/EP1294726A2/en not_active Withdrawn
- 2001-06-26 NZ NZ523011A patent/NZ523011A/en unknown
- 2001-06-26 WO PCT/GB2001/002846 patent/WO2002000662A1/en active IP Right Grant
- 2001-06-26 AU AU70748/01A patent/AU783640B2/en not_active Ceased
- 2001-06-26 CA CA002414089A patent/CA2414089A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2414089A1 (en) | 2002-01-03 |
EP1294726A2 (en) | 2003-03-26 |
JP2004501923A (en) | 2004-01-22 |
NZ523011A (en) | 2004-07-30 |
WO2002000662A1 (en) | 2002-01-03 |
AU783640B2 (en) | 2005-11-17 |
AU7074801A (en) | 2002-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002000662B1 (en) | Improvements in and relating to chromophores | |
AU703340B2 (en) | Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis | |
FR2678622B1 (en) | NEW VANADIUM COMPLEXES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
AU5460300A (en) | Peroxynitrite decomposition catalysts and methods of use thereof | |
JP2006515296A5 (en) | ||
CA2230960A1 (en) | Piperazine derivatives and process for the preparation thereof | |
Liang et al. | Study on nucleic acid (CT-DNA and yeast tRNA) binding behaviors and cytotoxic properties of a heterodinuclear Ru (II)–Co (III) polypyridyl complex | |
Koko et al. | Evaluation of the antiparasitic activities of imidazol‐2‐ylidene–gold (I) complexes | |
WO1998028311A1 (en) | Pharmaceutical aminophosphonic acid derivatives | |
WO2008113558A1 (en) | Amino-naphthyridine derivatives | |
US5561042A (en) | Diamine platinum naphthalimide complexes as antitumor agents | |
KR910007934A (en) | Tetracyclic compounds having anti-allergic and anti-asthmatic actions, methods for their preparation and uses | |
Kadoya et al. | Dicopper (II) complexes of p-cresol-2, 6-bis (dpa) amide-tether ligands: Large enhancement of oxidative DNA cleavage, cytotoxicity, and mechanistic insight by intracellular visualization | |
US6187787B1 (en) | Bis(9-aminoacridine) DNA intercalating agents having antitumor activity | |
RU2003103856A (en) | VARIOLIN DERIVATIVES, METHODS FOR THEIR PRODUCTION AND APPLICATION OF THE INDICATED SUBSTANCES AS ANTI-CANCER AGENTS | |
KR840001309B1 (en) | Process for the preparation of hetero allcylene bisanthraquinones | |
EP0618901A1 (en) | Highly water soluble bis-naphthalimides useful as anticancer agents. | |
Xu et al. | An eight-coordinate cage: synthesis and structure of the first macrotricyclic tetraterephthalamide ligand | |
WO2012007948A2 (en) | CYTOTOXIC Ti (IV) COMPOUNDS | |
US5461078A (en) | Anti-cancer compounds | |
TAKEDA et al. | A new synthesis of octaarylporphyrin: Naturally occurring porphyrin mimics | |
RU2002132558A (en) | CYCLOPOSTINES, METHOD FOR PRODUCING THEM AND THEIR USE | |
US7919500B2 (en) | Bis-carbazole DNA intercalating agents for antitumor therapy | |
Stevens et al. | Assembly of [FenSn (SPh) 4] 2-(n= 2, 4) and their iron-thiolate precursors in aqueous media | |
JP2000247978A (en) | Metal porphyrin complex and pharmaceutical composition containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: B1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: B1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
B | Later publication of amended claims | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2414089 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001949625 Country of ref document: EP Ref document number: 70748/01 Country of ref document: AU |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 523011 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2002 505786 Country of ref document: JP Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2001949625 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10312347 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 523011 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 523011 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 70748/01 Country of ref document: AU |